In Massachusetts, InVivo Therapeutics Holdings Corp., a biomaterials and biomedicals company focused on spinal cord injuries, hired Christopher McNulty as CFO as of March 29th. McNulty was a former SVP of Business Development and Investor Relations at InVivo and worked directly on a follow-on offering and direct financing projects. Prior to InVivo, he worked at Repligen leading its acquisition of Novozymes Sweden, and seemingly is a jack of all trades with degrees in electrical engineering and computer science from MIT as well as an MBA from Harvard. Melanie Morel-Ferris has been serving as the interim CFO and will stay on as Senior Director of Finance and Controller.
Latest article
New yoga fabric collection from Hyosung TNC and Lenzing “nama-stays” away from synthetic fibers
In South Korea, global elastane leader Hyosung TNC and Lenzing Group, a leading global producer of regenerated cellulosic fibers for the textile and nonwovens...
Egg carton kicks explore intersection of design and simplicity
In Prague, Kibardin Design has created a sneaker concept out of recycled egg cartons. Dubbed Egg Box Sneakers, the design project combines art, fashion...
Oyster waste provides pleasant “shell-ter” for Sydney parkgoers
In Sydney, Australia, a new Pier Pavilion designed by Besley & Spresser has been built using waste rock oyster shells.
Comprising a “striking landscape...